Search research articles
Contact Us
Filters
Showing results (251-260 of 280) with videos related to
Page
of 28
Sort By:
Anales Espanoles De Pediatria
|
March 20, 1999
[Lumbar puncture in a pediatric emergency department: something more than a diagnostic technic]
S Mintegui Raso, J Benito Fernández, J Sánchez Echániz, et al.
Ophthalmology
|
June 21, 2011
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study
David M Brown, Peter A Campochiaro, Robert B Bhisitkul, et al.
Neurotoxicity Research
|
November 17, 2004
IDRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients
G Ponce, J Hoenicka, R Rodríguez-Jiménez, et al.
Revista Clinica Espanola
|
April 29, 1998
[Prevalence of psychiatric disturbances and psychopathologic status in patients with systemic lupus erythematosus]
G Rubio Valladolid, A Gil Aguado, A Balsa Criado, et al.
The Journal of Pathology
|
November 1, 1995
Differential expression of the c-kit proto-oncogene in germ cell tumours
M A Izquierdo, P Van der Valk, J Van Ark-Otte, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 15, 2017
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo
Jean Carruthers, Nowell Solish, Shannon Humphrey, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 11, 2020
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
Sabrina G Fabi, Joel L Cohen, Lawrence J Green, et al.
Journal of the American Academy of Dermatology
|
July 14, 2025
Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study
Andrew Blauvelt, Petr Arenberger, Maxwell B Sauder, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 8, 2011
Psychometric properties of the Spanish version of the diagnostic interview for depressive personality
L J Irastorza, P Rojano, T Gonzalez-Salvador, et al.
Retina (Philadelphia, Pa.)
|
September 27, 2012
Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials
Neil M Bressler, David S Boyer, David F Williams, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 280) with videos related to
Sort By:
Page
of 28
Anales Espanoles De Pediatria
|
March 20, 1999
[Lumbar puncture in a pediatric emergency department: something more than a diagnostic technic]
S Mintegui Raso, J Benito Fernández, J Sánchez Echániz, et al.
Ophthalmology
|
June 21, 2011
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study
David M Brown, Peter A Campochiaro, Robert B Bhisitkul, et al.
Neurotoxicity Research
|
November 17, 2004
IDRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients
G Ponce, J Hoenicka, R Rodríguez-Jiménez, et al.
Revista Clinica Espanola
|
April 29, 1998
[Prevalence of psychiatric disturbances and psychopathologic status in patients with systemic lupus erythematosus]
G Rubio Valladolid, A Gil Aguado, A Balsa Criado, et al.
The Journal of Pathology
|
November 1, 1995
Differential expression of the c-kit proto-oncogene in germ cell tumours
M A Izquierdo, P Van der Valk, J Van Ark-Otte, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 15, 2017
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo
Jean Carruthers, Nowell Solish, Shannon Humphrey, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 11, 2020
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
Sabrina G Fabi, Joel L Cohen, Lawrence J Green, et al.
Journal of the American Academy of Dermatology
|
July 14, 2025
Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study
Andrew Blauvelt, Petr Arenberger, Maxwell B Sauder, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 8, 2011
Psychometric properties of the Spanish version of the diagnostic interview for depressive personality
L J Irastorza, P Rojano, T Gonzalez-Salvador, et al.
Retina (Philadelphia, Pa.)
|
September 27, 2012
Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials
Neil M Bressler, David S Boyer, David F Williams, et al.
Page
of 28